<DOC>
	<DOCNO>NCT00241527</DOCNO>
	<brief_summary>This study randomise , double-blind , parallel-group placebo control study compare efficacy esomeprazole 40 mg orally qd v placebo esomeprazole 20 mg orally qd vs placebo give patient continuous use NSAIDs , include COX-2 selective NSAIDs , treatment period 4 week relief upper GI symptom .</brief_summary>
	<brief_title>Esomeprazole Relief Upper Gastrointestinal Symptoms Associated With Continuous Use NSAIDs</brief_title>
	<detailed_description />
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Signed informed consent . 18 year age , old . Capable complete diary card . Ability complete HRQL questionnaire . A clinical diagnosis chronic condition ( e.g. , osteoarthritis rheumatoid arthritis ) require continuous daily NSAID treatment least 7 month . Daily NSAID treatment define take prescribed dose least 5 7 day give week include COX2 selective NSAIDs , multiple NSAIDs , highdose aspirin ( &gt; 325 mg/day ) . Daily NSAID treatment dose type : ( Must stable least 4 week prior baseline endoscopy ; Are expect remain stable duration study . ; Must administer orally duration study . If one type NSAID treatment use , least one type must give orally . ) Hp negative UBT , serology biopsy base test , visit 1 . Current , history , gastric duodenal ulcer Current , history , esophageal , gastric duodenal surgery . History GERD , associate NSAID use . Pain , discomfort burn upper abdomen precipitate exercise relieve defecation . Pain , discomfort burn upper abdomen associate use NSAIDs , include COX2 selective NSAIDs , judge investigator . Endoscopic Barrett 's esophagus ( &gt; 3 cm ) significant dysplastic change esophagus .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>